RxDoctor Payments DataLook up a doctor →

Maranda Eversoll, NP

Family · Flowood, MSNPI 1376072413

Payments from drug & device makers

$196,550in general payments, 2019–2025

Across 904 payments — averaging $217.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$132K
  • Takeda Pharmaceuticals U.S.A., Inc.$26K
  • AbbVie$17K
  • Lilly USA, LLC$6K
  • Celltrion USA Inc.$3K
  • E.r. Squibb & Sons, L.L.C.$3K
  • plus $10K from 25 others
$2,901in research payments, 2019–2025

Across 11 payments — averaging $263.75 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Sanofi US Services Inc.$3K

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$196,550 in reported general payments places this provider in the 95th percentile of 3,007 family providers in Mississippi.

See all family providers in Mississippi

Medicare billing

Part B allowed, 2024
$149,307
Medicare patients
267
Services billed
7,168

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family in Flowood

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →